Does a white male with a triglyceride level of 98 mg/dL, high‑density lipoprotein cholesterol of 62 mg/dL, and fasting insulin of 5.2 µU/mL have good insulin sensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessment of Insulin Sensitivity Based on Lipid and Insulin Parameters

This white male demonstrates excellent insulin sensitivity based on his favorable triglyceride-to-HDL ratio and low fasting insulin level.

Interpretation of the Triglyceride-to-HDL Ratio

The triglyceride-to-HDL cholesterol ratio is a validated surrogate marker for insulin resistance in white populations, and this patient's values are highly favorable:

  • Calculated TG/HDL ratio: 1.58 (98 mg/dL ÷ 62 mg/dL)
  • This falls well below the optimal cut-point of 2.5 for men that identifies insulin resistance 1
  • Research demonstrates that TG/HDL ratios >3.5 in men identify insulin-resistant subgroups with significantly higher fasting insulin, blood pressure, BMI, and cardiometabolic risk 1
  • In white European populations specifically, the TG/HDL ratio shows strong correlation with insulin resistance (area under ROC curve 0.74-0.75), making it a reliable screening tool 2

The optimal cut-points for detecting insulin resistance range from 0.9-1.7 mmol/L (2.0-3.8 mg/dL) for the TG/HDL ratio, and this patient's value of 1.58 is at the lower end of this range, suggesting good insulin sensitivity 2.

Fasting Insulin Assessment

The fasting insulin of 5.2 µU/mL strongly supports insulin sensitivity:

  • This value is substantially below the threshold of 13.13 µU/mL used to define insulin resistance 3
  • Research identifies an optimal cut-point of 109 pmol/L (approximately 15 µU/mL) for fasting insulin to detect insulin resistance, with 57% sensitivity and 85% specificity 4
  • The patient's fasting insulin is less than half this threshold, indicating robust insulin sensitivity

Clinical Significance of Combined Markers

When both markers are favorable, as in this case, insulin sensitivity is highly likely:

  • Studies demonstrate that plasma triglyceride concentration and the TG/HDL ratio are among the most useful metabolic markers for identifying insulin-resistant individuals, with sensitivity of 64-67% and specificity of 68-71% 4
  • A weighted combination of fasting insulin and triglycerides provides higher sensitivity while maintaining specificity compared to using fasting insulin alone 5
  • This patient's triglycerides (98 mg/dL) are well below the optimal cut-point of 130 mg/dL for identifying insulin resistance 4

Race-Specific Considerations

The interpretation is particularly reliable because the patient is white:

  • The TG/HDL ratio performs as an acceptable marker of insulin resistance in whites (AUC 0.77 for men) but is a poor predictor in African Americans (AUC 0.63) 3
  • Racial differences exist because African Americans have significantly lower triglycerides and TG/HDL ratios despite comparable or higher insulin levels 3, 6
  • Guidelines explicitly state that routine insulin testing is not recommended for most individuals with or at risk for diabetes, as these assays are primarily useful for research purposes 6

Important Caveats

While these markers suggest good insulin sensitivity, recognize their limitations:

  • The sensitivity of TG/HDL ratio and fasting insulin to detect insulin resistance is only 40-67%, meaning some insulin-resistant individuals may be missed 1, 4
  • The specificity is better at 68-85%, so a favorable result (as in this case) is more reliable for ruling out insulin resistance 1, 4
  • Gold standard measurement remains the euglycemic insulin clamp, but this is impractical for clinical use 5

Related Questions

Does the triglyceride‑to‑HDL‑cholesterol ratio indicate insulin resistance?
What is the recommended approach to evaluate insulin resistance in an overweight adult with risk factors (central obesity, family history of type 2 diabetes, hypertension, dyslipidemia, sedentary lifestyle, prior gestational diabetes) and how should it be managed?
What is the best test for diagnosing insulin resistance in adults with a body mass index (BMI) above 25?
How do you diagnose insulin resistance?
At what body fat percentage does insulin resistance first begin?
What is cerebral palsy?
In a healthy adult, what is the likely cause of transient hoarseness after exercise and how should it be managed?
What is the most likely cause of nighttime fussiness and crying in a 2‑month‑old infant born at 34 weeks gestation after formula feeds and burping?
Please review my medication list—baclofen 20 mg extended‑release twice daily, nebivolol 5 mg nightly, pyridostigmine 60 mg nightly, pentoxifylline 400 mg extended‑release twice daily, benfotiamine 300 mg daily, tadalafil 5 mg daily after breakfast, montelukast 10 mg nightly, lemborexant 5 mg nightly, tranexamic acid 250 mg three times daily, plus B‑complex with vitamin C and zinc, pyridoxal‑5‑phosphate 50 mg, and methylcobalamin 1500 µg alternate days—for chronic upper and mid‑back muscle pain with full‑body stiffness, resting tachycardia/autonomic imbalance (mast‑cell activation syndrome), erectile dysfunction, insomnia, and melasma—what changes are recommended to optimize efficacy and safety?
Is it safe to take losartan 50 mg together with the potassium chloride from chips (≈2.5 g potassium per day) in a patient with normal renal function and no other potassium‑retaining medications?
In a white male with low triglycerides, high HDL, and low fasting insulin, does an HbA1c of 5.6% suggest prolonged red‑cell lifespan, and what test would confirm altered red‑cell turnover?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.